The biotech sector is also one of the supposed winners of the COVID 19 pandemic. Although spending in the health sector has been cut in numerous countries, this movement is now likely to be upturned. Problems in managing the corona crisis were particularly tackled by countries in which the government, as well as the health insurance companies, had been using a red pencil for years. Here in this article, you’ll find the top 10 biotechnology companies in the world 2021
Of course, this trend also marks the research and development work of the biotech sector. Because the topic of health has become a hot topic, therefore, investors also invest in it. The biotech industry is benefiting from the influxes of money so that the stocks in the industry have been among the stock market’s outperformers for some months.
Top 10 biotechnology companies in the world 2021
Here is a list of the top 10 biotechnology companies in the world 2021
1- Alexion Pharmaceuticals(ALXN) ~$115
Alexion is an international biopharmaceutical company that focuses on helping patients and families that are affected by rare diseases through the finding, development, and commercialization of life-changing therapies.
2- Amgen (AMGN) ~$255
Amgen is considered one of the world’s foremost biotechnology companies. It is a leading company whose main focus is on science and innovation to transmute new ideas and discoveries into medicines for patients with thoughtful illnesses.
Amgen (AMGN ) was established in 1980 as AMGEN (Applied Molecular Genetics) and is reflected as a pioneer in the industry.
The world’s major biotech company with a fair capitalization of USD 145 billion has been listed on the NASDAQ meanwhile 1983.
The chief research areas of the biotech group comprise the areas of blood, bone diseases, liver and kidney diseases, neurology, cancer, rheumatology, diabetes, and cell therapy. The supplementary value ranges from the recognition of an active ingredient through its R & D to the manufacture and sale of the ended medicine.
3- Biogen (BIIB) ~$281
The mission of Biogen is clear. They are innovators in neuroscience. Since its establishment in 1978 as one of the world’s first international biotechnology companies, Biogen has led groundbreaking scientific research with the aim to defeat overwhelming neurological diseases.
4- Emergent Biosolutions (EBS) ~$103
Emergent commenced as a private business with a single product with a single location. Through the flexibility and hard work of its employees, Emergent has changed into a thriving global public company seeking to recover lives around the world.
5- Genmab (GMAB) ~$36
The main focus of Genmab is on the creation and development of groundbreaking and distinguished antibody products, with the purpose of improving the lives of cancer patients.
6- Gilead Sciences (GILD) ~$62
For more than 30 years, Gilead worked determinedly to bring forward medicines for severe diseases. Gilead’s Vision is to generate a better, healthier world for all people. Its mission is to discover, develop, and deliver groundbreaking therapeutics for people with serious diseases.
7- Halozyme Therapeutics (HALO) ~$26
Firstly, Halozyme is a biotechnology industry that focuses on new biological and drug delivery tactics. Secondly, their goal is to bring groundbreaking and disruptive solutions that mend the patient experience and, potentially patient outcomes when their technology is joined with established or evolving treatments.
Thirdly, Halozyme (HALO) is a reasonably small biotech company that emphasizes the commercialization and development of novel cancer therapies.
In modern years, the company was worth around USD 3.6 billion on the stock exchange. Due to one-off sales, the sales statistics have also been comparatively volatile in recent years. But now the company is on a strong growth path.
8- Horizon Therapeutics (HZNP) ~$80
It was established in 2008 as a startup with only a few employees and no office space. Horizon now has over 1,200 employees that focus on helping those wedged by rare and rheumatic conditions.
9- Regeneron Pharmaceuticals (REGN) ~$575
Regeneron is an American-based Biotechnology Company situated in Tarrytown, New York. The company was established in 1988. And is now a leading biotechnology company that developing vital medicines for people with serious illnesses.
Regeneron Pharmaceutical referred to as REGN is a prominent biotechnology company evolving vital medicines for people with grave illnesses. This is a New York-based company that was established 30 years ago by only 2 doctors and scientists. The company’s medicines help patients with eye diseases, cardiovascular and metabolic diseases, neuromuscular diseases, allergic and inflammatory diseases, cancer, infectious diseases, and some rare diseases.
10- Vertex Pharmaceuticals (VTRX) ~$273
Vertex Pharmaceuticals incorporation is also an American-based Biopharmaceutical Company situated in Boston, Massachusetts. It was one of the 1st biotech firms to use a clear strategy of lucid drug design rather than combinatorial chemistry.
See also top 10 academic publishers 2021